Guideline for the treatment of Parkinson's disease

South African Medical Journal

Volumn 99, Issue 10, 2009, Pages 755-758

  Carr, J ^a   Kies, B ^a   Fine, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BOTULINUM TOXIN; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOMPERIDONE; FLUDROCORTISONE; LAXATIVE; LEVODOPA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PYRIDOSTIGMINE; RASAGILINE; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT;

AUTONOMIC DYSFUNCTION; BLADDER DYSFUNCTION; BRAIN CORTEX; COGNITION; CONSTIPATION; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DYSKINESIA; FREEZING; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; MORBIDITY; MOTOR PERFORMANCE; MOTOR SYSTEM; PARKINSON DISEASE; PRACTICE GUIDELINE; PSYCHOSIS; REM SLEEP; SEROTONINERGIC SYSTEM; SHORT SURVEY; SYMPTOM; TREMOR; UNSPECIFIED SIDE EFFECT; WORKING MEMORY;

ANTIPARKINSON AGENTS; CHOLINERGIC ANTAGONISTS; DISEASE PROGRESSION; DOPAMINE AGONISTS; HUMANS; LEVODOPA; MONOAMINE OXIDASE INHIBITORS; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 70450163091     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Bergareche ADeLaPE, Lopez dM, Sarasqueta C, de Arce A, Poza JJ, Marti-Masso JF. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol 2004; 251: 340-345.
2. Tanner CM, Ottman R, Goldman SM, et al. Parkinson's disease in twins: an etiologic study. JAMA 1999; 281: 376-378.
3. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211. (Pubitemid 36007810)
4. Rascol O, Brooks DJ, Korczyn AD, De DP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000; 342: 1484-1491. (Pubitemid 30318272)
5. Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol 2003; 54: 235-238. (Pubitemid 36909622)
6. Parkinson's Study Group. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol 2004; 61: 561-566.